- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent | 2 | GlobeNewswire (USA) | ||
| Do | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 06.12. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 04.12. | Mangoceuticals untersucht ungewöhnliche Aktienaktivitäten nach Aktiensplit | 2 | Investing.com Deutsch | ||
| 04.12. | Mangoceuticals probes unusual stock activity post-split | 3 | Investing.com | ||
| MANGOCEUTICALS Aktie jetzt für 0€ handeln | |||||
| 04.12. | Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split | 49 | GlobeNewswire (Europe) | DALLAS, TX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness products... ► Artikel lesen | |
| 12.11. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 01.11. | MGRX stock touches 52-week low at $2.1 amid market challenges | 1 | Investing.com | ||
| 31.10. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.10. | Mangoceuticals issues shares, raises $78,787 in capital | 1 | Investing.com | ||
| 22.10. | MangoRx hits back at Eli Lilly's weight loss drug copycat claims | 6 | Pharmaceutical Technology | ||
| 22.10. | Mangoceuticals Opts For Strategic Alternatives | 1 | RTTNews | ||
| 22.10. | Mangoceuticals explores strategic alternatives to boost shareholder value | 2 | Investing.com | ||
| 22.10. | Mangoceuticals To Defend Against Eli Lilly's Lawsuit Over Alleged Copying Of Weight-Loss Drugs | 407 | AFX News | INDIANAPOLIS (dpa-AFX) - Mangoceuticals Inc. (MGRX) announced that Eli Lilly has made public allegations and filed a lawsuit against the company, claiming that MangoRx improperly copied its... ► Artikel lesen | |
| 22.10. | Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit | 6 | Seeking Alpha | ||
| 21.10. | MangoRx faces lawsuit from Eli Lilly over medication | 5 | Investing.com | ||
| 21.10. | Mangoceuticals, Inc.: MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly | 213 | GlobeNewswire (Europe) | Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness... ► Artikel lesen | |
| 21.10. | MANGOCEUTICALS, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.10. | Centurion One Capital Corp.: Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 | 273 | Newsfile | Dallas, Texas--(Newsfile Corp. - October 18, 2024) - Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling men's health and wellness products via a secure telemedicine... ► Artikel lesen | |
| 11.10. | Mangoceuticals announces 1-for-15 reverse stock split | 3 | Seeking Alpha |
Seite:
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SPINEWAY | 0,077 | -4,70 % | Spineway wins new approvals in Vietnam and registers initial orders | Press release Ecully, December 18, 2024 - 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment... ► Artikel lesen | |
| EMEIS | 5,376 | +0,62 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
| NANO-X IMAGING | 7,015 | -0,78 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| LOGICMARK | 1,595 | -2,74 % | LogicMark, Inc. Announces Reverse Stock Splits | LOUISVILLE, Ky., Nov. 15, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK) (the "Company"), a provider of personal emergency response systems (PERS), health communications devices, and technology... ► Artikel lesen | |
| NUWELLIS, INC | 1,090 | +2,83 % | Nuwellis, Inc.: Nuwellis Regains Compliance with Nasdaq Listing Requirements | MINNEAPOLIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (the "Company" or "Nuwellis") today announced that the Company received formal written notice from The Nasdaq Stock Market... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,085 | +2,15 % | Butterfly Network (NYSE:BFLY) Shares Down 6.3% - What's Next? | ||
| CARMAT | 1,022 | -3,04 % | CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group) which will be allocated to the repayment of its financial debt | Buy-back by CARMAT of 2 million shares from Airbus for a symbolic sum of 1 euro. The shares so bought-back will be allocated to the repayment of the Company's financial debt, via their... ► Artikel lesen | |
| GOODRX | 4,445 | -1,66 % | GoodRx Reports Third Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released... ► Artikel lesen | |
| TALKSPACE | 3,040 | +1,33 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| JOINT CORP | 10,100 | +0,30 % | JOINT Corp - 8-K, Current Report | ||
| MIMEDX | 9,140 | -1,40 % | MiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 83,46 | +2,85 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HYPERFINE | 0,870 | +0,80 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| ATRICURE | 30,420 | -0,30 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen |
MANGOCEUTICALS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +2,02 % bei einem Aktienkurs von 2,530 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MANGOCEUTICALS INC finden Sie auf Wallstreet Online.
